John J. McCabe, Senior Vice President, Finance at Eleven Biotherapeutics, Inc. (EBIO), sold 1,501 shares at $0.27 ($405) on 2016-02-16, disclosed to the SEC on 2016-02-17.
Open-market sale of $405 EBIO by Senior Vice President, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |